ArticleOphthalmology and therapy2026

Early Outcomes of Intravitreal Aflibercept 8 mg in Eyes Previously Treated with Aflibercept 2 mg for Neovascular Age-Related Macular Degeneration with AI-Based Biomarker Quantification.

Nicolò Bartolomeo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.